Michael Thorn

1.4k total citations
28 papers, 1.1k citations indexed

About

Michael Thorn is a scholar working on Cardiology and Cardiovascular Medicine, Psychiatry and Mental health and Surgery. According to data from OpenAlex, Michael Thorn has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 5 papers in Psychiatry and Mental health and 4 papers in Surgery. Recurrent topics in Michael Thorn's work include Cardiac electrophysiology and arrhythmias (6 papers), Epilepsy research and treatment (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Michael Thorn is often cited by papers focused on Cardiac electrophysiology and arrhythmias (6 papers), Epilepsy research and treatment (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Michael Thorn collaborates with scholars based in United States, Japan and South Africa. Michael Thorn's co-authors include Michael B. Tennison, Craig Versek, John B. O’Connor, Mark Tuominen, Robert Greenwood, S. Thayumanavan, Darrell V. Lewis, Richard H. Gracely, Daniel J. Clauw and R. Michael Gendreau and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Oncology.

In The Last Decade

Michael Thorn

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Thorn United States 19 299 220 198 193 175 28 1.1k
Bo‐Hyung Kim South Korea 19 154 0.5× 157 0.7× 126 0.6× 157 0.8× 87 0.5× 108 1.3k
Li‐Chia Chen United Kingdom 20 104 0.3× 187 0.8× 115 0.6× 86 0.4× 129 0.7× 89 1.3k
Angélica Vargas Mexico 19 460 1.5× 288 1.3× 348 1.8× 51 0.3× 54 0.3× 40 2.4k
Rohit Bhatia India 24 261 0.9× 57 0.3× 141 0.7× 80 0.4× 111 0.6× 129 1.8k
John R. Rice United States 18 274 0.9× 343 1.6× 68 0.3× 74 0.4× 42 0.2× 29 1.4k
Susan M. Cheer New Zealand 18 157 0.5× 206 0.9× 165 0.8× 89 0.5× 63 0.4× 30 1.1k
Hitoshi Ishii Japan 28 82 0.3× 81 0.4× 289 1.5× 71 0.4× 91 0.5× 134 2.7k
Chien‐Liang Liu Taiwan 31 342 1.1× 23 0.1× 412 2.1× 216 1.1× 82 0.5× 96 2.9k
Chien‐Yu Chen Taiwan 21 88 0.3× 69 0.3× 360 1.8× 46 0.2× 41 0.2× 58 1.2k

Countries citing papers authored by Michael Thorn

Since Specialization
Citations

This map shows the geographic impact of Michael Thorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Thorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Thorn more than expected).

Fields of papers citing papers by Michael Thorn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Thorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Thorn. The network helps show where Michael Thorn may publish in the future.

Co-authorship network of co-authors of Michael Thorn

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Thorn. A scholar is included among the top collaborators of Michael Thorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Thorn. Michael Thorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kleiman, Robert, Börje Darpö, Michael Thorn, Thomas Stoehr, & Frank Schippers. (2020). Potential strategy for assessing QT/QTc interval for drugs that produce rapid changes in heart rate: Electrocardiographic assessment of the effects of intravenous remimazolam on cardiac repolarization. British Journal of Clinical Pharmacology. 86(8). 1600–1609. 24 indexed citations
2.
Collins, Sean P., Michael Thorn, Richard M. Nowak, et al.. (2017). Feasibility of Serial 6-min Walk Tests in Patients with Acute Heart Failure. Journal of Clinical Medicine. 6(9). 84–84. 6 indexed citations
3.
Room, Robin, et al.. (2014). Limits on trading hours, particularly late-night trading. 122–136. 3 indexed citations
4.
Edwards, John, et al.. (2013). Vilazodone lacks proarrhythmogenic potential in healthy participants: a thorough ECG study. International Journal of Clinical Pharmacology and Therapeutics. 51(6). 456–465. 9 indexed citations
6.
Thorn, Michael, Craig Versek, Ambata Poe, et al.. (2010). Enhancement of anhydrous proton transport by supramolecular nanochannels in comb polymers. Nature Chemistry. 2(6). 503–508. 146 indexed citations
7.
Martwiset, Surangkhana, Özgür Yavuzçetin, Michael Thorn, et al.. (2008). Proton conducting polymers containing 1H‐1,2,3‐triazole moieties. Journal of Polymer Science Part A Polymer Chemistry. 47(1). 188–196. 37 indexed citations
8.
Thorn, Michael, Mark D. Smucker, James Allan, et al.. (2008). InterNano: e-Science for the Nanomanufacturing Community. 382–383. 2 indexed citations
9.
Ross, Helen J., Lowell L. Hart, Paul Swanson, et al.. (2006). A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma. Lung Cancer. 54(1). 69–77. 29 indexed citations
10.
Thorn, Michael, et al.. (2005). A prospective study of factors that determine cecal intubation time at colonoscopy. Gastrointestinal Endoscopy. 61(1). 72–75. 160 indexed citations
11.
Gendreau, R. Michael, Michael Thorn, J. Gendreau, et al.. (2005). Efficacy of milnacipran in patients with fibromyalgia.. PubMed. 32(10). 1975–85. 191 indexed citations
12.
Sueta, Carla A., Mihai Gheorghiade, Kirkwood F. Adams, et al.. (1995). Safety and efficacy of epoprostenol in patients with severe congestive heart failure. The American Journal of Cardiology. 75(3). 34A–43A. 60 indexed citations
13.
Tennison, Michael B., Robert Greenwood, Darrell V. Lewis, & Michael Thorn. (1994). Discontinuing Antiepileptic Drugs in Children with Epilepsy: A Comparison of a Six-Week and a Nine-Month Taper Period. New England Journal of Medicine. 330(20). 1407–1410. 89 indexed citations
14.
Torres, Ramón A., et al.. (1993). Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. The American Journal of Medicine. 95(6). 573–583. 54 indexed citations
15.
Miles, Michael V., Michael B. Tennison, Robert Greenwood, et al.. (1990). Evaluation of the Ames Seralyzer for the Determination of Carbamazepine, Phenobarbital, and Phenytoin Concentrations in Saliva. Therapeutic Drug Monitoring. 12(5). 501–510. 29 indexed citations
16.
Miles, Michael V., et al.. (1989). Effects of Enteral Tube Feeding on the Absorption and Pharmacokinetic Profile of Carbamazepine Suspension. Epilepsia. 30(3). 364–369. 20 indexed citations
17.
Tennison, Michael B., Michael V. Miles, Gary M. Pollack, Michael Thorn, & Robert E. Dupuis. (1988). Valproate Metabolites and Hepatotoxicity in an Epileptic Population. Epilepsia. 29(5). 543–547. 35 indexed citations
18.
Abernathy, James R., Michael Thorn, Lars‐Göran Ekelund, et al.. (1988). Correlates of systolic and diastolic blood pressure in men 40 to 59 years of age sampled from United States of America and Union of Soviet Socialist Republics lipid research clinics populations. The American Journal of Cardiology. 61(13). 1071–1075. 8 indexed citations
20.
Ingram, Deborah D., Michael Thorn, Sandra S. Stinnett, & А. Д. Деев. (1985). U.S.S.R. and U.S. nutrient intake, plasma lipids, and lipoproteins in men ages 40–59 sampled from lipid research clinics populations. Preventive Medicine. 14(3). 264–271. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026